Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004686802 | SCV005183976 | uncertain significance | not specified | 2024-03-28 | criteria provided, single submitter | clinical testing | The c.6964C>T (p.P2322S) alteration is located in exon 10 (coding exon 9) of the ZFHX4 gene. This alteration results from a C to T substitution at nucleotide position 6964, causing the proline (P) at amino acid position 2322 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003899546 | SCV004712318 | likely benign | ZFHX4-related disorder | 2023-06-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |